A health economic analysis of clinical islet transplantation-Reference-Cited by-同舟云学术

A health economic analysis of clinical islet transplantation

Published:2011-02-16 Issue:1 Volume:26 Page:23-33
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:

Author:

Beckwith Jessica,Nyman John A.,Flanagan Brian,Schrover Rudolf,Schuurman Henk-Jan

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0012.2011.01411.x/fullpdf

Reference45 articles.

1. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen;Shapiro;N Engl J Med,2000

2. The Clinical Islet Transplantation (CIT) Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in patients with type 1 diabetes http://www.citisletstudy.org/

3. Severe hypoglycaemia in 1076 adult patients with type diabetes: influence of risk markers and selection;Pedersen-Bjergaard;Diabetes Metab Res Rev,2004

4. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002;Cowie;Diabetes Care,2006

5. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes;Cryer;Diabetes,2005

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France;The Lancet Diabetes & Endocrinology;2024-09

2. Advances in alginate encapsulation of pancreatic islets for immunoprotection in type 1 diabetes;Journal of Pharmaceutical Investigation;2023-06-29

3. Islet Allotransplantation;Transplantation of the Pancreas;2023

4. Treatment of Pancreatic Exocrine Disorders by Pancreas and Islet Transplantation;Transplantation of the Pancreas;2023

5. Islet Immunoengineering;Pluripotent Stem Cell Therapy for Diabetes;2023